Clinical Trials for Cardiff Oncology

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Cardiff Oncology

Clinical Trials (5)

NCT06736717
Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer
PHASE1/PHASE2Recruiting
21 participants
Started: Feb 28, 2025 · Completed: Jan 31, 2027
1 condition2 sponsors1 location
NCT06106308
Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation
PHASE2Active, not recruiting
113 participants
Started: Feb 27, 2024 · Completed: Jan 31, 2027
3 conditions2 sponsors41 locations
NCT05383196
Onvansertib + Paclitaxel In TNBC
PHASE1/PHASE2Active, not recruiting
50 participants
Started: Sep 30, 2022 · Completed: Feb 15, 2029
10 conditions2 sponsors3 locations
NCT05450965
Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer
PHASE2Recruiting
37 participants
Started: Jul 19, 2022 · Completed: Nov 30, 2027
2 conditions3 sponsors2 locations
NCT04005690
Targeted Pathway Inhibition in Patients With Pancreatic Cancer
EARLY_PHASE1Recruiting
90 participants
Started: Aug 1, 2019 · Completed: Feb 1, 2028
8 conditions5 sponsors1 location